Serveur d'exploration sur les interactions arbre microorganisme

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

How Membrane-Active Peptides Get into Lipid Membranes.

Identifieur interne : 000159 ( Main/Exploration ); précédent : 000158; suivant : 000160

How Membrane-Active Peptides Get into Lipid Membranes.

Auteurs : Marc-Antoine Sani [Australie] ; Frances Separovic [Australie]

Source :

RBID : pubmed:27187572

Descripteurs français

English descriptors

Abstract

The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms. Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid composition. In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed. AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors. They are extremely diverse in amino acid composition and often show specificity against a particular strain of microbe. Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative. In an effort to understand their molecular mechanism, biophysical studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads. Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid composition or secondary structure remains elusive. A common feature of these membrane-active peptides is their preference for the lipid environment. Indeed, they are mainly unstructured in solution and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity. These steps define the molecular mechanism by which these membrane-active peptides lyse membranes. The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles. CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism. A critical aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane composition of the cell target. Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in composition and structure. The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane composition could be identified. NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment. Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.

DOI: 10.1021/acs.accounts.6b00074
PubMed: 27187572


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">How Membrane-Active Peptides Get into Lipid Membranes.</title>
<author>
<name sortKey="Sani, Marc Antoine" sort="Sani, Marc Antoine" uniqKey="Sani M" first="Marc-Antoine" last="Sani">Marc-Antoine Sani</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010</wicri:regionArea>
<wicri:noRegion>Victoria 3010</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Separovic, Frances" sort="Separovic, Frances" uniqKey="Separovic F" first="Frances" last="Separovic">Frances Separovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010</wicri:regionArea>
<wicri:noRegion>Victoria 3010</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27187572</idno>
<idno type="pmid">27187572</idno>
<idno type="doi">10.1021/acs.accounts.6b00074</idno>
<idno type="wicri:Area/Main/Corpus">000158</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000158</idno>
<idno type="wicri:Area/Main/Curation">000158</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000158</idno>
<idno type="wicri:Area/Main/Exploration">000158</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">How Membrane-Active Peptides Get into Lipid Membranes.</title>
<author>
<name sortKey="Sani, Marc Antoine" sort="Sani, Marc Antoine" uniqKey="Sani M" first="Marc-Antoine" last="Sani">Marc-Antoine Sani</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010</wicri:regionArea>
<wicri:noRegion>Victoria 3010</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Separovic, Frances" sort="Separovic, Frances" uniqKey="Separovic F" first="Frances" last="Separovic">Frances Separovic</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010</wicri:regionArea>
<wicri:noRegion>Victoria 3010</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Accounts of chemical research</title>
<idno type="eISSN">1520-4898</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Lipid Bilayers (metabolism)</term>
<term>Membrane Proteins (chemistry)</term>
<term>Membrane Proteins (metabolism)</term>
<term>Peptides (chemistry)</term>
<term>Peptides (metabolism)</term>
<term>Protein Transport (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Double couche lipidique (métabolisme)</term>
<term>Peptides (composition chimique)</term>
<term>Peptides (métabolisme)</term>
<term>Protéines membranaires (composition chimique)</term>
<term>Protéines membranaires (métabolisme)</term>
<term>Séquence d'acides aminés (MeSH)</term>
<term>Transport des protéines (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Membrane Proteins</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Lipid Bilayers</term>
<term>Membrane Proteins</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Peptides</term>
<term>Protéines membranaires</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Double couche lipidique</term>
<term>Peptides</term>
<term>Protéines membranaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Protein Transport</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Séquence d'acides aminés</term>
<term>Transport des protéines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms. Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid composition. In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed. AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors. They are extremely diverse in amino acid composition and often show specificity against a particular strain of microbe. Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative. In an effort to understand their molecular mechanism, biophysical studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads. Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid composition or secondary structure remains elusive. A common feature of these membrane-active peptides is their preference for the lipid environment. Indeed, they are mainly unstructured in solution and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity. These steps define the molecular mechanism by which these membrane-active peptides lyse membranes. The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles. CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism. A critical aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane composition of the cell target. Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in composition and structure. The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane composition could be identified. NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment. Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27187572</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>03</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>03</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1520-4898</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>49</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2016</Year>
<Month>06</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Accounts of chemical research</Title>
<ISOAbbreviation>Acc Chem Res</ISOAbbreviation>
</Journal>
<ArticleTitle>How Membrane-Active Peptides Get into Lipid Membranes.</ArticleTitle>
<Pagination>
<MedlinePgn>1130-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.accounts.6b00074</ELocationID>
<Abstract>
<AbstractText>The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms. Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid composition. In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed. AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors. They are extremely diverse in amino acid composition and often show specificity against a particular strain of microbe. Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative. In an effort to understand their molecular mechanism, biophysical studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads. Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid composition or secondary structure remains elusive. A common feature of these membrane-active peptides is their preference for the lipid environment. Indeed, they are mainly unstructured in solution and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity. These steps define the molecular mechanism by which these membrane-active peptides lyse membranes. The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles. CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism. A critical aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane composition of the cell target. Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in composition and structure. The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane composition could be identified. NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment. Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sani</LastName>
<ForeName>Marc-Antoine</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Separovic</LastName>
<ForeName>Frances</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>School of Chemistry, Bio21 Institute, University of Melbourne , Melbourne, Victoria 3010, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>05</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Acc Chem Res</MedlineTA>
<NlmUniqueID>0157313</NlmUniqueID>
<ISSNLinking>0001-4842</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008051" MajorTopicYN="N">Lipid Bilayers</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27187572</ArticleId>
<ArticleId IdType="doi">10.1021/acs.accounts.6b00074</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Sani, Marc Antoine" sort="Sani, Marc Antoine" uniqKey="Sani M" first="Marc-Antoine" last="Sani">Marc-Antoine Sani</name>
</noRegion>
<name sortKey="Separovic, Frances" sort="Separovic, Frances" uniqKey="Separovic F" first="Frances" last="Separovic">Frances Separovic</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/TreeMicInterV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000159 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000159 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    TreeMicInterV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27187572
   |texte=   How Membrane-Active Peptides Get into Lipid Membranes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27187572" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a TreeMicInterV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Thu Nov 19 16:52:21 2020. Site generation: Thu Nov 19 16:52:50 2020